MedTrace Logo

Liver Transplantation for Unresectable Perihilar Cholangiocarcinoma

NCT06986486 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 8

Last updated 2025-05-23

No results posted yet for this study

Summary

This is multicentric, single-arm, observational, investigator-drive study investigating the efficacy of liver transplantation after successful downstaging/disease control of unresectable perihilar cholangiocarcinoma using chemotherapy +/- immunotherapy and stereotactic body radiation therapy (SBRT).

Conditions

  • Perihilar Cholangiocarcinoma
  • Klatskin Tumor

Sponsors & Collaborators

  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-01
Primary Completion
2030-01-01
Completion
2030-01-01

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06986486 on ClinicalTrials.gov